Interplay of posttranslational modifications in Sp1 mediates Sp1 stability during cell cycle progression

Journal of Molecular Biology

Volumn 414, Issue 1, 2011, Pages 1-14

  Wang, Yi Ting ^a   Yang, Wen Bin ^c   Chang, Wen Chang ^a,b,c   Hung, Jan Jong ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

phosphorylation; RNF4; sumoylation; ubiquitin E3 ligase

Indexed keywords

PROTEIN RNF4; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SP1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SUMOYLATION; UBIQUITINATION;

EID: 81055156560     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.09.027     Document Type: Article

References (56)

1. Bouwman P., and Philipsen S. Regulation of the activity of Sp1-related transcription factors Mol. Cell. Endocrinol. 195 2002 27 38 (Pubitemid 35287159)
2. Deniaud E., Baguet J., Mathieu A.L., Pages G., Marvel J., and Leverrier Y. Overexpression of Sp1 transcription factor induces apoptosis Oncogene 25 2006 7096 7105 (Pubitemid 44722077)
3. Wong C.F., Barnes L.M., Dahler A.L., Smith L., Popa C., Serewko-Auret M.M., and Saunders N.A. E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line Oncogene 24 2005 3525 3534 (Pubitemid 40756253)
4. Chu S., and Ferro T.J. Sp1: regulation of gene expression by phosphorylation Gene 348 2005 1 11 (Pubitemid 40410011)
5. Black A.R., Black J.D., and Azizkhan-Clifford J. Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer J. Cell. Physiol. 188 2001 143 160 (Pubitemid 32622905)
6. Hung J.J., Wang Y.T., and Chang W.C. Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription Mol. Cell. Biol. 26 2006 1770 1785
7. Mortensen E.R., Marks P.A., Shiotani A., and Merchant J.L. Epidermal growth factor and okadaic acid stimulate Sp1 proteolysis J. Biol. Chem. 272 1997 16540 16547 (Pubitemid 27276482)
8. Abdelrahim M., and Safe S. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins Mol. Pharmacol. 68 2005 317 329 (Pubitemid 41058295)
9. Wang Y.T., Chuang J.Y., Shen M.R., Yang W.B., Chang W.C., and Hung J.J. Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process J. Mol. Biol. 380 2008 869 885
10. 2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis Mol. Biol. Cell 19 2008 1139 1151
11. Higgins K.J., Abdelrahim M., Liu S., Yoon K., and Safe S. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins Biochem. Biophys. Res. Commun. 345 2006 292 301 (Pubitemid 44269283)
12. Wang X.B., Peng W.Q., Yi Z.J., Zhu S.L., and Gan Q.H. Expression and prognostic value of transcriptional factor sp1 in breast cancer Ai Zheng 26 2007 996 1000
13. Cip1/WAF1 gene in a Sp1-dependent manner Endocr.-Relat. Cancer 15 2008 545 557 (Pubitemid 351880842)
14. Xu K., and Shu H.K. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas Cancer Res. 67 2007 6121 6129 (Pubitemid 47037492)
15. Benasciutti E., Pages G., Kenzior O., Folk W., Blasi F., and Crippa M.P. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription Blood 104 2004 256 262 (Pubitemid 38879866)
16. 3 Oncogene 23 2004 4856 4861
17. Waf1 in HeLa cells FEBS Lett. 564 2004 199 204 (Pubitemid 38490724)
18. Kip1 by the VDR/Sp1 complex J. Cell. Biochem. 98 2006 1450 1456
19. Huang P.H., Wang D., Chuang H.C., Wei S., Kulp S.K., and Chen C.S. α-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis Carcinogenesis 30 2009 1125 1131
20. Chen B.K., Huang C.C., Chang W.C., Chen Y.J., Kikkawa U., Nakahama K., and Morita I. PP2B-mediated dephosphorylation of c-Jun C terminus regulates phorbol ester-induced c-Jun/Sp1 interaction in A431 cells Mol. Biol. Cell 18 2007 1118 1127 (Pubitemid 46399514)
21. Sudhakar C., Jain N., and Swarup G. Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin FEBS J. 275 2008 2200 2213 (Pubitemid 351569559)
22. McClure R.F., Heppelmann C.J., and Paya C.V. Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1 J. Biol. Chem. 274 1999 7756 7762
23. Chou C.F., Peng H.W., Wang C.Y., Yang Y.T., and Han S.H. An Sp1 binding site involves the transcription of the Fas ligand gene induced by PMA and ionomycin in Jurkat cells J. Biomed. Sci. 7 2000 136 143
24. Desterro J.M., Rodriguez M.S., and Hay R.T. SUMO-1 modification of IκBα inhibits NF-κB activation Mol. Cell 2 1998 233 239 (Pubitemid 128373648)
25. Bies J., Markus J., and Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity J. Biol. Chem. 277 2002 8999 9009 (Pubitemid 34952972)
26. Gill G. Something about SUMO inhibits transcription Curr. Opin. Genet. Dev. 15 2005 536 541 (Pubitemid 41262410)
27. Sun H., Leverson J.D., and Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins EMBO J. 26 2007 4102 4112 (Pubitemid 47462098)
28. Heideker J., Perry J.J., and Boddy M.N. Genome stability roles of SUMO-targeted ubiquitin ligases DNA Repair 8 2009 517 524
29. Prudden J., Pebernard S., Raffa G., Slavin D.A., Perry J.J., and Tainer J.A. SUMO-targeted ubiquitin ligases in genome stability EMBO J. 26 2007 4089 4101 (Pubitemid 47462097)
30. Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N., and Jaffray E.G. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation Nat. Cell Biol. 10 2008 538 546 (Pubitemid 351627373)
31. Lallemand-Breitenbach V., Jeanne M., Benhenda S., Nasr R., Lei M., and Peres L. Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway Nat. Cell Biol. 10 2008 547 555 (Pubitemid 351627374)
32. Weisshaar S.R., Keusekotten K., Krause A., Horst C., Springer H.M., and Gottsche K. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML FEBS Lett. 582 2008 3174 3178
33. Geoffroy M.C., Jaffray E.G., Walker K.J., and Hay R.T. Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies Mol. Biol. Cell 21 2010 4227 4239
34. van Hagen M., Overmeer R.M., Abolvardi S.S., and Vertegaal A.C. RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated hypoxia-inducible factor-2α Nucleic Acids Res. 38 2010 1922 1931
35. Martin N., Schwamborn K., Schreiber V., Werner A., Guillier C., and Zhang X.D. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock EMBO J. 28 2009 3534 3548
36. Fedele M., Benvenuto G., Pero R., Majello B., Battista S., and Lembo F. A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor J. Biol. Chem. 275 2000 7894 7901 (Pubitemid 30159697)
37. Hakli M., Karvonen U., Janne O.A., and Palvimo J.J. The RING finger protein SNURF is a bifunctional protein possessing DNA binding activity J. Biol. Chem. 276 2001 23653 23660
38. Lyngso C., Bouteiller G., Damgaard C.K., Ryom D., Sanchez-Munoz S., and Norby P.L. Interaction between the transcription factor SPBP and the positive cofactor RNF4. An interplay between protein binding zinc fingers J. Biol. Chem. 275 2000 26144 26149
39. Pero R., Lembo F., Palmieri E.A., Vitiello C., Fedele M., and Fusco A. PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription J. Biol. Chem. 277 2002 3280 3285 (Pubitemid 34953193)
40. Poukka H., Karvonen U., Yoshikawa N., Tanaka H., Palvimo J.J., and Janne O.A. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor J. Cell Sci. 113 2000 2991 3001
41. Curtin D., Ferris H.A., Hakli M., Gibson M., Janne O.A., Palvimo J.J., and Shupnik M.A. Small nuclear RING finger protein stimulates the rat luteinizing hormone-β promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression Mol. Endocrinol. 18 2004 1263 1276 (Pubitemid 38591290)
42. Kaiser F.J., Moroy T., Chang G.T., Horsthemke B., and Ludecke H.J. The RING finger protein RNF4, a co-regulator of transcription, interacts with the TRPS1 transcription factor J. Biol. Chem. 278 2003 38780 38785 (Pubitemid 37221777)
43. Hakli M., Lorick K.L., Weissman A.M., Janne O.A., and Palvimo J.J. Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity FEBS Lett. 560 2004 56 62 (Pubitemid 38264293)
44. Hakli M., Karvonen U., Janne O.A., and Palvimo J.J. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies Exp. Cell Res. 304 2005 224 233 (Pubitemid 40222089)
45. Bruderer R., Tatham M.H., Plechanovova A., Matic I., Garg A.K., and Hay R.T. Purification and identification of endogenous polySUMO conjugates EMBO Rep. 12 2011 142 148
46. Spengler M.L., and Brattain M.G. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription J. Biol. Chem. 281 2006 5567 5574 (Pubitemid 43847653)
47. Bonello M.R., and Khachigian L.M. Fibroblast growth factor-2 represses platelet-derived growth factor receptor-α (PDGFR-α) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-α promoter J. Biol. Chem. 279 2004 2377 2382 (Pubitemid 38114220)
48. Tan N.Y., and Khachigian L.M. Sp1 phosphorylation and its regulation of gene transcription Mol. Cell. Biol. 29 2009 2483 2488
49. Spengler M.L., Guo L.W., and Brattain M.G. Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation Cell Cycle 7 2008 623 630 (Pubitemid 351499001)
50. Abdel-Hafiz H., Dudevoir M.L., and Horwitz K.B. Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation J. Biol. Chem. 284 2009 9099 9108
51. Muller S., Matunis M.J., and Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus EMBO J. 17 1998 61 70 (Pubitemid 28041048)
52. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., and Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification J. Biol. Chem. 275 2000 13321 13329 (Pubitemid 30257389)
53. Yang S.H., Jaffray E., Senthinathan B., Hay R.T., and Sharrocks A.D. SUMO and transcriptional repression: dynamic interactions between the MAP kinase and SUMO pathways Cell Cycle 2 2003 528 530
54. Wei S., Chuang H.C., Tsai W.C., Yang H.C., Ho S.R., and Paterson A.J. Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the up-regulation of β-transducin repeat-containing protein Mol. Pharmacol. 76 2009 47 57
55. Su K., Roos M.D., Yang X., Han I., Paterson A.J., and Kudlow J.E. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro J. Biol. Chem. 274 1999 15194 15202
56. Bortnick B., El-Khalili N., Banov M., Adson D., Datto C., and Raines S. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study J. Affect. Disord. 128 2011 83 94